PHARMACOKINETICS OF HIGH-DOSE INTRAVENOUS MELPHALAN IN CHILDREN AND ADULTS WITH FORCED DIURESIS - REPORT IN 26 CASES

被引：48

作者：

ARDIET, C

TRANCHAND, B

BIRON, P

REBATTU, P

PHILIP, T

机构：

来源：

关键词：

D O I：

10.1007/BF00293997

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：300 / 305

页数：6

共 16 条

[1] ALBERTS DS, 1979, CANCER TREAT REV, V6, P51
[2] BOSANQUET AG, 1984, CANCER CHEMOTH PHARM, V12, P183
[3] PHARMACOLOGY OF INTRAVENOUS MELPHALAN IN PATIENTS WITH MULTIPLE-MYELOMA
BROX, L
BIRKETT, L
BELCH, A
[J]. CANCER TREATMENT REVIEWS, 1979, 6 : 27 - 32
[4] CHANG SY, 1978, J PHARM SCI, V5, P679
[5] CORNWELL GG, 1982, CANCER TREAT REP, V66, P475
[6] DINCALCI M, 1982, CANCER CHEMOTH PHARM, V7, P141
[7] GIBALDI M, 1975, PHARMACOKINETICS, pCH2
[8] PHARM - AN INTERACTIVE GRAPHIC PROGRAM FOR INDIVIDUAL AND POPULATION PHARMACOKINETIC PARAMETER-ESTIMATION
GOMENI, R
[J]. COMPUTERS IN BIOLOGY AND MEDICINE, 1984, 14 (01) : 25 - 34
[9] GOUYETTE A, 1986, CANCER CHEMOTHER PHA
[10] ESTIMATION OF CREATININE CLEARANCE FROM SERUM CREATININE CONCENTRATION - REVIEW
LOTT, RS
HAYTON, WL
[J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1978, 12 (03): : 140 - 150